Cannabinoid Medicines

GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH), a developer of cannabinoid prescription medicines, saw its stock surge Monday after the company reported positive results from a clinical study. Wall Street took notice with some firms reaffirming their bullish stance on the stock and placing price...